Return On Assets in % of ArriVent BioPharma, Inc. from Q3 2024 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
ArriVent BioPharma, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2024 to Q3 2025.
  • ArriVent BioPharma, Inc. Return On Assets for the quarter ending September 30, 2025 was -55.7 %, a 87.8% decline year-over-year.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Return On Assets, Annual (%)

ArriVent BioPharma, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -55.7 -26.1 -87.8% Jul 1, 2025 Sep 30, 2025
Q2 2025 -52.1 Apr 1, 2025 Jun 30, 2025
Q1 2025 -46.7 Jan 1, 2025 Mar 31, 2025
Q4 2024 -26.7 Oct 1, 2024 Dec 31, 2024
Q3 2024 -29.7 Jul 1, 2024 Sep 30, 2024

ArriVent BioPharma, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -26.7 Jan 1, 2024 Dec 31, 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.